Hepatology Home > Hepatology
| S.No | Brand Name | Composition | Packing | Pack |
|---|---|---|---|---|
| 1 | UDB-300 | URSODEOXYCHOLIC ACID IP 300MG | ALU-ALU | 10X10 |
| 2 | LIVREPAIR-M | METADOXIN IP 500MG L-ORNItdINE L-ASPARTATE 150MG SILYMARIN (100%) 140MG PYRIDOXIN HCL IP 3MG FOLIC ACID IP 1.5MG (17.5MM DS) IN TABLET | ALU-ALU | 10X10 |
| 3 | LIVREPAIR | L-ORNItdINE L-ASPARTATE 250MG SILYMARIN (100%) 140MG (17.5MM DS) IN FOOD TABLET | ALU-ALU | 10X10 |
| 4 | HEPALIV | LECItdIN IP 125MG SILYMARIN(70%) 35MG | WItd METALLIC CARTON | 200ML |
| 5 | LIVREPAIR | TRICHOLINE CITRATE 65% 250MG L-ORNItdINE L-ASPARTATE 50MG NIACINAMIDE 45MG SILYMARIN 80% 40MG ZINC GLUCONATE 2.5MG VITAMIN B6 1.5MG SODIUM SELENATE 100MCG VITAMIN B12 1MCG SORBITOL BASE(SUGAR FREE) | WItd METALLIC CARTON | 200ML |
| 6 | MAXLIVER-DS | TRICHOLINE CITERATE0.55GM LIVER TONIC (MINT FLAVOURED SYP.) | WItd METALLIC CARTON | 200ML |
| 7 | BLUCYP-T | CYPROHEPTADINE HCL 2 MG TRICHOLINE CITRATE 0.275GM | WItd METALLIC CARTON | 200ML |
| 8 | REAPPETIZER | APPETITE STIMULATER(CYPROHEPTADINE TRICHOLINE CITRATE IN SORBITOL BASE) | WItd METALLIC CARTON | 200ML |
| 9 | BLUMOL-SPAS | DICYCLOMINE HCL 20MG PARACETAMOL 325MG | BLISTER | 20X12 |
| 10 | BLUMEF-SPAS | MEFENAMIC ACID 250MG DICYCLOMINE HCL10MG | NIM TYPE BLISTER | 10X10 |
| 11 | BLUFEN-SPAS | ACECLO 100MG DROTAVERINE 80MG | BLISTER | 10X10 |
Hepatology PCD Pharma Franchise: Explore Business Opportunities in Liver Care Medicines
The hepatic ailment medicines market in India is evolving rapidly to attain the status of domestic reach of ₹4,200 crore and is anticipated to cross ₹9,500 crore in 2030. By establishing your hepatology PCD Pharma Franchise, you will be in a position to meet the local demands for the treatment of metabolic ailments, NAFLD, & viral hepatitis.
For the success of your business, you need GMP-certified manufacturing units, high-grade silymarin preparations, and special L-ornithine L-Aspartat. The standard initial investment in setting up a PCD franchise amounts to ₹60,000 to ₹2.5 lakh. Choosing a good hepatology PCD pharma company will give you access to high formula stability, effective local promotional tools & a substantial gross margin of 35% to 55%.
Contact Us At: +91-8062750200
How Does a Hepatology PCD Pharma Franchise Offer Business Opportunities in Liver Diseases Treatment?
Target Growing Local Demand for Formulations
There is a rising demand for efficient medicines for liver care from local patients owing to increased intake of alcoholic drinks, NAFLD and poor nutrition. Setting up a hepatology PCD pharma franchise will give you the
Obtain Exclusive District Monopoly Agreement
Manufacturing companies issue formal agreements on monopoly in certain geographical territories. The partnership with a Hepatology PCD Pharma Company will protect your distribution rights and prevent price cutting by other competitors in the local area.
Get Access to Advanced Formulations
Modern manufacturing facilities produce such hepatoprotective medications as ursodeoxycholic acid and L-glutathione. Partnering with a specialized hepatology pharma franchise company will give you constant access to stable and DCGI-certified formulas for treatment of liver diseases.
Avoid Huge Financial Burden on Set Up Operations
Opening a franchise eliminates the necessity of huge financial investments in the purchase of land, equipment, and factory operation. Partnership with a hepatology PCD Franchise in India will allow you to start your commercial distribution in only 10-15 days.
Use Comprehensive Promotional Marketing Kit
Parent brands offer a full set of promotional materials, including visual aids, sample catch cover, and technical information. Working with a Hepatology PCD Pharma Franchise platform will allow you to save money on marketing while earning the trust of local physicians.
What Medicines for Liver Care Are Commonly Contained in a Hepatology PCD Pharma Franchise?
| Therapeutic Segments | Active Ingredients & Dosage Strength | Value for Business & Medicine |
|---|---|---|
| Hepatoprotectors | Silymarin 140 mg + B-complex capsules | Preservation of liver cells & regeneration of enzymes |
| Biliary Acid Secretor | Ursodeoxycholic Acid (UDCA) 300 mg tablets | Treatment of gallstone formation and enhanced bile secretion |
| Amino Acid Infusions | L-Ornithine L-aspartate 500 mg/5 ml syrup | Reduction in blood ammonia levels in hepatic encephalopathy |
| Antioxidants | L-Glutathione 500 mg + N-acetylcysteine tablets | Mitigation of the effects of free radicals & toxic metabolic products |
| Ayurvedic Medicines for Liver Tonic | Kalmegh + Bhringraj + Kutki herbal syrups | Enhancement in appetite, digestion and natural liver detoxification |
Visit Us At: Plot no. 11-12, Dainik Bhaskar, Sector-25-d, Chandigarh-160014, India
What Are the Considerations to Make Prior to Launching a PCD Pharma Hepatology Franchise ?
Market analysis and budget calculation would be required for the launch of a hepatology franchise. Before signing an agreement, the future business owner has to assess local clinical demand, prices in the competition, and target medical specialties. It is possible to launch a hepatology pharmaceutical business with a small initial investment, which amounts to ₹60,000 to ₹2.5 lakh.
- Make sure that the manufacturing partner has all required WHO-GMP, ISO 9001:2015, and DCGI certificates.
- Ensure that all the important permits from the state are in place; this will involve a Wholesale Drug License and also the GST registration number.
- Look through the product catalog of the manufacturing partner to ensure consistency in the supply of the liver caps, syrup, and injectable.
- Know the basic information about MOQ, pricing, and discounts.
- Study the promotional samples offered by the brand, which include visual aids, glossary, and reminder cards.
Why Should You Opt for Blue Water Research for Hepatology PCD Pharma Franchise?
Modern Infrastructure in the Manufacturing Plant
It consists of a modern manufacturing plant equipped with clean room technology and liquid filling machinery. Partnership with the company will ensure uniformity in each commercial batch.
Formulations Have Superior Bioavailability
The company uses high-purity active substances for the production of stable and efficient liver supplements and liquid suspensions. Partnership with the Hepatology PCD Franchise in India will give you guaranteed therapeutic effect and reliable treatment.
Exclusive District Monopoly Rights
Bluewater Research offers exclusive territorial rights to protect your business from any competition. Partnership with the hepatology pharma franchise company will prevent aggressive local price slashing.
Low Initial Capital Investment
The company offers affordable starting packages, requiring an initial investment amount of ₹60,000 to ₹1.5 lakh. Partnership with a hepatology PCD pharma franchise network allows small business owners to grow without any problems.
Fast Order Processing and Express Logistics
Bluewater Research has big distribution centers filled with a full range of liver care products. By using the platform, you will be able to get your orders processed and delivered within 24 hours.
Conclusion
Choice of a manufacturing partner is one of the key factors influencing the success of your liver care business. A Hepatology Pharma Franchise Company offers reliable product quality, a monopoly agreement, and necessary marketing support. Bluewater Research combines advanced manufacturing technologies with a wide therapeutic portfolio to guarantee stable business development.
Whatever the level of your initial capital – ₹60,000 or higher up to ₹5 lakh. The company will offer you dependable and practical assistance. The hepatology PCD pharma franchise will allow you to build a reputation among healthcare specialists and receive substantial commercial income.
Frequently Asked Questions
Q1. What is the minimum investment to launch a hepatology PCD pharma franchise?
Ans. Most companies let you open operations for the initial investment of ₹60,000 to ₹2 lakh, covering stocks and marketing materials.
Q2. What licenses are required to distribute hepatology drugs in India?
Ans. You need to have a valid Wholesale Drug License, GST registration number and personal identification documents (PAN, identity proof).
Q3. How does silymarin help to restore liver in children and adults?
Ans. This element acts as a good antioxidant, protecting the cell membrane of the liver from any toxins that may be detrimental and enabling liver tissue regrowth.
Q4. How profitable are the sales of hepatology medications for the distributors?
Ans. Generally, franchise holders make a gross profit of 35%-55% depending on the number of orders, the type of products and local market demand.
Q5. Are monopoly rights provided under a hepatology PCD franchise agreement?
Ans. Yes, reputed parent companies provide signed Monopoly PCD agreements, granting exclusive distribution and marketing rights within your assigned district.
Q6. What kind of marketing support is offered by parent companies to franchise partners?
Ans. The companies offer visual aids, sample catch covers, medical representative bags, prescription pads, and detailed product reference books.
Q7. Why is ursodeoxycholic acid (UDCA) widely prescribed in hepatology practice?
Ans. UDCA decreases the rate of cholesterol absorption in the gallbladder, dissolving gallstones and protecting liver cells from damage done by toxic bile acids.
Q8. Is it possible for a medical representative to launch an independent hepatology PCD pharma franchise?
Ans. Yes, many experienced medical representatives decide to launch independent franchises since they already have good relations with local doctors and clinics.
Q9. In what way is L-ornithine-L-aspartate helpful for managing hepatic encephalopathy?
Ans. It helps in the process of converting additional ammonia into urea and glutamine, thus lowering the level of ammonia in the blood.
Q10. How much time is required for dispatch and delivery of the franchise package order?
Ans. Orders are usually dispatched in 24-48 hours and are delivered to the nearby region in 3-7 days through road transport.